Pool JL - Search Results

1

Terazosin (Hytrin): cumulative experience of clinical trials in the USA for the treatment of mild to moderate essential hypertension.

Pool JL, Nelson EB, Taylor AA, Mitchell JR. Pool JL, et al. Br J Clin Pract Suppl. 1987 Dec;54:9-14. Br J Clin Pract Suppl. 1987. PMID: 2905162 Clinical Trial. No abstract available.

2

Review of the effects of doxazosin, a new selective alpha 1-adrenergic inhibitor, on lipoproteins in patients with essential hypertension.

Pool JL, Taylor AA, Nelson EB. Pool JL, et al. Am J Med. 1989 Aug 16;87(2A):57S-61S. doi: 10.1016/0002-9343(89)90115-0. Am J Med. 1989. PMID: 2569825 Review.

3

Clinical role of direct renin inhibition in hypertension.

Taylor AA, Pool JL. Taylor AA, et al. Among authors: pool jl. Am J Ther. 2012 May;19(3):204-10. doi: 10.1097/MJT.0b013e3182068da5. Am J Ther. 2012. PMID: 21317620

4

Clinical experience and rationale for angiotensin-converting enzyme inhibition with lisinopril as the initial treatment for hypertension in older patients.

Pool JL, Nelson EB, Taylor AA. Pool JL, et al. Am J Med. 1988 Sep 23;85(3B):19-24. doi: 10.1016/0002-9343(88)90345-2. Am J Med. 1988. PMID: 2844082 Review.

5

Combined terazosin and verapamil therapy in essential hypertension. Hemodynamic and pharmacokinetic interactions.

Lenz ML, Pool JL, Laddu AR, Varghese A, Johnston W, Taylor AA. Lenz ML, et al. Among authors: pool jl. Am J Hypertens. 1995 Feb;8(2):133-45. doi: 10.1016/0895-7061(94)00162-5. Am J Hypertens. 1995. PMID: 7755941 Clinical Trial.

6

Controlled multicenter study of the antihypertensive effects of lisinopril, hydrochlorothiazide, and lisinopril plus hydrochlorothiazide in the treatment of 394 patients with mild to moderate essential hypertension.

Pool JL, Gennari J, Goldstein R, Kochar MS, Lewin AJ, Maxwell MH, McChesney JA, Mehta J, Nash DT, Nelson EB, et al. Pool JL, et al. J Cardiovasc Pharmacol. 1987;9 Suppl 3:S36-42. doi: 10.1097/00005344-198700003-00010. J Cardiovasc Pharmacol. 1987. PMID: 2442550 Clinical Trial.

7

Propylbutyldopamine. Mechanism of blood pressure lowering in hypertensive patients.

Taylor AA, Fennell WH, Ruud CO, Pool JL, Nelson EB, Ginos JZ, Mitchell JR. Taylor AA, et al. Among authors: pool jl. Hypertension. 1984 Mar-Apr;6(2 Pt 2):I40-5. doi: 10.1161/01.hyp.6.2_pt_2.i40. Hypertension. 1984. PMID: 6373598 Clinical Trial.

8

Antihypertensive activity of isradipine in humans: a new dihydropyridine calcium channel antagonist.

Nelson EB, Pool JL, Taylor AA. Nelson EB, et al. Among authors: pool jl. Clin Pharmacol Ther. 1986 Dec;40(6):694-7. doi: 10.1038/clpt.1986.246. Clin Pharmacol Ther. 1986. PMID: 2946507 Clinical Trial.

9

Renin-aldosterone profiling in hypertension.

Mitchell JR, Taylor AA, Pool JL, Lake CR, Rollins DE, Bartter FC. Mitchell JR, et al. Among authors: pool jl. Ann Intern Med. 1977 Nov;87(5):596-312. doi: 10.7326/0003-4819-87-5-596. Ann Intern Med. 1977. PMID: 335942 Clinical Trial.

10

Alpha 1-adrenoreceptor blockade and the molecular basis of lipid metabolism alterations.

Pool JL, Lenz ML, Taylor AA. Pool JL, et al. J Hum Hypertens. 1990 Oct;4 Suppl 3:23-33. J Hum Hypertens. 1990. PMID: 1979819

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

218 results

Search Page

Filters